Draft Guidelines for Safe Use of Subcutaneous Insulin Delivery across the Continuum of Care. | AHRQ Patient Safety Network

Draft Guidelines for Safe Use of Subcutaneous Insulin Delivery across the Continuum of Care. | AHRQ Patient Safety Network

• Measurement Tool/Indicator
 
• Published April 2016

Draft Guidelines for Safe Use of Subcutaneous Insulin Delivery across the Continuum of Care.

Horsham, PA: Institute for Safe Medication Practices; April 8, 2016.

Insulin is a high-alert medication that can cause patient harm if administered incorrectly. This announcement calls for field comments on guidelines developed to ensure the safe use of subcutaneous insulin. The deadline for submitting comments is April 30, 2016.

Available at

Related Resources

JOURNAL ARTICLE › STUDY

Does an insulin double-checking procedure improve patient safety?

Modic MB, Albert NM, Sun Z, et al. J Nurs Adm. 2016;46:154-160.

NEWSPAPER/MAGAZINE ARTICLE

Misadministration of IV insulin associated with dose measurement and hyperkalemia treatment.

ISMP Medication Safety Alert! Acute Care Edition. August 11, 2011;16:1-3.

JOURNAL ARTICLE › STUDY

Reducing potentially fatal errors associated with high doses of insulin: a successful multifaceted multidisciplinary prevention strategy.

Dooley MJ, Wiseman M, McRae A, et al. BMJ Qual Saf. 2011;20:637-644.

NEWSPAPER/MAGAZINE ARTICLE

Medication errors common for hospital diabetes.

Nursing Times. April 1, 2011.

JOURNAL ARTICLE › COMMENTARY

Addressing safety concerns about U-500 insulin in a hospital setting.

Samaan KH, Dahlke M, Stover J. Am J Health Syst Pharm. 2011;68:63-68.

View More